INDmoney
Bicara Therapeutics Stock Performance
as on March 6, 2026 at 7:59 am IST
Day's Low
Day's High
$17.71$18.82
4.17%
Downside
1.84%
Upside
52 Week's Low
52 Week's High
$7.80$19.7157.79%
Downside
6.66%
Upside
Bicara Therapeutics share price movements today
- Previous Close
- $18.54
- Open
- $18.38
- Volume
- 1.0M
- Day's Low - High
- $17.71 - $18.82
- 52 Week Low - High
- $7.80 - $19.71
Bicara Therapeutics Historical Returns
- 1 Month Return
- + 20.44 %
- 3 Month Return
- + 1.65 %
- 1 Year Return
- + 17.46 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Bicara Therapeutics Stock Fundamentals & Key Indicators
Check Bicara Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.0B
EPS (TTM)
-2.479
Dividend Yield
0.00%
PE Ratio (TTM)
3.45
Industry PE ratio
0PEG Ratio
0Return On Equity TTM
-26.64%
Bicara Therapeutics Stock Valuation
Track how Bicara Therapeutics P/E has moved over time to understand its valuation trends.
Bicara Therapeutics in the last 5 years
Lowest (-12.44x)
September 30, 2024
Industry (0.00x)
March 6, 2026
Today (3.45x)
March 6, 2026
Highest (-3.76x)
June 30, 2025
Today’s Price to Earnings Ratio: 3.45x
Bicara Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Bicara Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $1.0B | NA | 3.45 | 0.00% | |
| BUY | $43.4B | 123.52% | 141.08 | 8.45% | |
| BUY | $121.4B | 117.39% | 31.15 | 32.94% | |
| NA | $33.1B | NA | 586.31 | 5.37% | |
| BUY | $83.3B | 65.72% | 18.98 | 31.41% |
Stock Returns calculator for Bicara Therapeutics Stock including INR - Dollar returns
The Bicara Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Bicara Therapeutics investment value today
Current value as on today
₹1,22,706
Returns
₹22,706
(+22.71%)
Returns from Bicara Therapeutics Stock
₹17,333 (+17.33%)
Dollar Returns*
₹5,372 (+5.37%)
Bicara Therapeutics Stock’s Investor Sentiment and Interest
Search interest for Bicara Therapeutics Stock has increased by 40% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:40% versus previous 30 day period
Bicara Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Bicara Therapeutics Annual Profit & Loss
All numbers in Millions USD
Bicara Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Bicara Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on Bicara Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, BCAX stock has moved up by 10.3%
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 29.2% return, outperforming this stock by 11.7%
About Bicara Therapeutics
| Organisation | Bicara Therapeutics |
| Headquarters | 116 Huntington Avenue, Boston, MA, United States, 02116 |
| CEO | Dr. Claire Mazumdar Clemon M.B.A., Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Bicara Therapeutics
Name | Title |
|---|---|
Mr. Ivan Hyep M.B.A. | Chief Financial Officer |
Ms. Lara S. Meisner J.D. | Chief Legal Officer & Corporate Secretary |
Ms. Pauline Dufresne | Chief People Officer |
Dr. David Raben M.D. | Chief Medical Officer |
Ms. Angela Windt | VP & Head of Regulatory Affairs |
Dr. Claire Mazumdar Clemon M.B.A., Ph.D. | CEO & Director |
Ms. Rachel Salazar | SVP of R&D Strategy and Operations |
Ms. Sathish Hasige Ph.D. | Senior VP and Head of Technical Operations & Supply Chain |
Dr. Jeltje Schulten M.B.A., M.D. | Senior Vice President of Clinical & Medical Affairs |
Mr. Ryan Cohlhepp Pharm.D. | President, COO & Director |
FAQs
What is Bicara Therapeutics share price today?
Bicara Therapeutics share price today is $18.48 as on at the close of the market. Bicara Therapeutics share today touched a day high of $18.82 and a low of $17.71.
What is the 52 week high and 52 week low for Bicara Therapeutics share?
Bicara Therapeutics share touched a 52 week high of $19.71 on and a 52 week low of $7.8 on . Bicara Therapeutics stock price today i.e. is closed at $18.48,which is 6.24% down from its 52 week high and 136.92% up from its 52 week low.
What is Bicara Therapeutics's market capitalisation today?
Bicara Therapeutics market capitalisation is $0.00T as on .
How to invest in Bicara Therapeutics Stock (BCAX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Bicara Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bicara Therapeutics Shares that will get you 0.0812 shares as per Bicara Therapeutics share price of $18.48 per share as on March 6, 2026 at 2:29 am IST.
What is the minimum amount required to buy Bicara Therapeutics Stock (BCAX) from India?
Indian investors can start investing in Bicara Therapeutics (BCAX) shares with as little as ₹91.558 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹915.58 in Bicara Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Bicara Therapeutics share’s latest price of $18.48 as on March 6, 2026 at 2:29 am IST, you will get 0.5411 shares of Bicara Therapeutics. Learn more about
fractional shares .